Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

"The system is really getting in the way," said a pediatric pulmonologist. After many trips to the doctor's office, five-year ...

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of ...

Also Read: Amgen/AstraZeneca’s Asthma Drug Tezspire Vs. Sanofi/Regeneron’s Blockbuster Dupixent – Analyst Gives His Pick WAYPOINT is a randomized, double-blind trial that evaluated the ...

Asthma is associated with memory problems in children, a new study has found. Further, the early onset of asthma might worsen ...

The South San Francisco, Calif., biopharmaceutical company in May shut down two trials of zelnecirnon, which was being evaluated as a treatment for asthma and atopic dermatitis.

Youngsters with the condition performed worse at memory tasks in a study that followed 500 participants for two years ...

Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in Journal of Allergy and ...

One of the reasons that Black children have higher rates of asthma is their comorbid conditions. For instance, obesity is ...

AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.